ESR1 and breast cancer: In a Denmark-based study comparing more than 10 thousand breast cancer patients by age groups, the younger age category (under 35 years and 35–39 years old) showed a higher risk of death and worse prognosis, as well as more advanced node-positive disease, higher histological grade and ER negativity [29].